From: Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)
t–AUC (Nomogram)
t–AUC (AJCC Stage)
P–value
6–month
0.766
0.546
< 0.001
12–month
0.715
0.554
18–month
0.703
0.557